Serum bactericidal activity of ceftazidime: Continuous infusion versus intermittent injections

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 1, 1996, Pages 61-64

  Nicolau, David P ^a,b   Nightingale, Charles H ^a,b   Banevicius, Mary Anne ^a   Fu, Qiang ^a   Quintiliani, Richard ^a,c  

^a HARTFORD HOSPITAL   (United States)

^b UNIVERSITY OF CONNECTICUT   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME ARGININE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG INTERMITTENT THERAPY; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL;

EID: 0030067791     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.1.61     Document Type: Article

References (24)

1. Barriere, S. L., E. Ely, J. E. Kapusnik, and J. G. Gambertoglio. 1985. Analysis of a new method for assessing activity of combinations of antimicrobials: area under the bactericidal activity curve. J. Antimicrob. Chemother. 16:49-59.
2. Bodey, G. P., S. J. Ketchel, and V. Rodriquez. 1979. A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. Am. J. Med. 67:608-611
3. Castela, N., A. M. Taburet, J. Carlet, G. Nitenberg, M. Wolff, J. P. Sollet, J. J. Lefevre, and E. Singlas. 1994 Pharmacokinetics of ceftazidime during continuous infusion in intensive care patients, abstr. A11. In Abstract of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology. Washington. D.C
4. Coppa, G. F., J. J. Hoballah, G. J. Jonas, and L. A. Sudarsky. 1992. Pharmacokinetics of continuous-infusion intravenous antibiotics during operations for abdominal trauma. Infect Med. 11:48-52.
5. Craig, W. A., and S. C. Ebert. 1992. Continuous infusion of β-lactam antibiotics Antimicrob Agents Chemother 36:2577-2583.
6. Ebert, S. C., and W. A. Craig. 1990. Pharmacodynamic properties of antibiotics' application to drug monitoring and dosage regimen design. Infect Control Hosp. Epidermiol 11:319-326
7. Gibaldi, M., and D. Perrier. 1982. Noncompartmental analysis based on statistical moment theory, p. 409-417. In J. Swarbrick (ed.). Pharmacokinetics, 2nd ed , Marcel Dekker, Inc., New York
8. Kalman, D., S. L. Barriere, and B. L. Johnson, Jr. 1992. Pharmacokinetic disposition and bactericidal activities of cefepimie, ceftazidime, and cefperazone in serum and blister fluid. Antimicrob. Agents Chemother 36:453-457
9. Livingston, D. H., and M. T. Wang. 1993 Continuous infusion of cefazolin is superior to intermittent dosing in decreasing infection after hemorrhagic shock. Am. J. Surg. 165:203-207.
10. Mordenti, J. J., R. Qunitiliani, and C. H. Nightingale. 1985 Combination antibiotic therapy comparison of constant infusion and intermittent bolus dosing in an experimental animal model J. Antimicrob. Chemother. 15:313-321.
11. Mouton, J. W., and J. G. den Hollander. 1994 Killing of Pseudomonas aeniginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model Antimicrob. Agents Chemother. 38:931-936.
12. Mouton, J. W., A. M. Horrevorts, P. G. H. Mulder, E. P. Prens, and M. F. Michel. 1990. Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers Antimicrob. Agents Chemother. 34:2307-2311.
13. National Committee for Clinical Laboratory Standards. 1987. Methodology for the serum bactericidal test. Proposed guideline M21-P. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. National Committee for Clinical Laboratory Standards. 1990 Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 2nd ed. Approved standard M7-A2. National Committee for Clinical Laboratory Standards, Villanova, Pa.
15. Nicolau, D. P., C. H. Nightingale, M. A. Banevicius, Q. Fu, and R. Quintiliani. 1994. Ceftazidime serum bactericidal activity: continuous infusion versus intermittent injections, abstr. A90, p. 118. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
16. Nicolau, D. P., and R. Quintiliani. 1994. Choosing among the new cephalosporin antibiotics: a pharmacodynamic approach. PharmacoEconomics 5(Suppl. 2):34-39.
17. Nicolau, D. P., R. Quintiliani, and C. H. Nightingale. 1992. Once-daily aminoglycosides. Conn. Med. 56:561-563.
18. Nightingale, C. H., R. Quintiliani, and D. P. Nicolau. 1994 Intelligent dosing of antimicrobials, p. 252-265. In J. S. Remington, M. N. Swartz (ed ), Current clinical topics in infectious diseases, vol. 14. Blackwell Scientific, Cambridge.
19. Onyeji, C. O., D. P. Nicolau, C. H. Nightingale, and R. Quintiliani. 1994. Optimal duration of time above the minimum inhibitory concentrations of ceftibuten and cefaclor in experimental intra-abdominal infections. Antimicrob. Agents Chemother. 38:1112-1117.
20. Peterson, L. R., D. N. Gerding, and C. E. Fasching. 1981 Effects of method of antibiotic administration on extravascular penetration: cross-over study of cefazolin given by intermittent injection or constant infusion. J. Antimicrob. Chemother. 7:71-79.
21. Relier, L. B., and C. W. Stratton. 1977. Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility tests J. Infect. Dis. 136:196-204
22. Roosendaal, R., L A. J. M. Bakker-Woudenburg, J. C. van den Berg, and M. F. Michel. 1985. Therapeutic efficacy of continuous versus intermittent administration of ceftazidime in an experimental Klebseilla pneumoniae pneumonia in rats J Infect. Dis 152:373-378
23. Vogelman, B., S. Gundmundsson, J. Legget, J. Turnidge, S. Ebert, and W. A. Craig. 1988 Corielation of antimicrobial pharmacokinetic parameters with efficacy in an animal model. J. Infect. Dis. 158:831-847
24. Zeisler, J. A., J. D. McCarthy, W. A. Richelieu, and M. B. Nichol. 1992 Cefuroxime by continuous infusion: a new standard of care? Infect. Med. 11:54-60.